Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma

被引:3
作者
Zhang, Chunhui [1 ]
Tao, Yuqing [1 ]
Yang, Rui [1 ]
Wang, Yueqi [1 ]
Yu, Yanyan [2 ]
Zhou, Yang [2 ,3 ]
机构
[1] Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Pathol, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Dept Radiol, Harbin, Peoples R China
[3] Harbin Med Univ, Canc Hosp, Dept Radiol, 150 Haping Rd, Harbin 150010, Heilongjiang, Peoples R China
关键词
hepatocellular carcinoma; salvage liver transplantation; non -transplantable recurrence; treatment; prognosis; ALPHA-FETOPROTEIN; RISK-FACTORS; FEATURES; SINGLE;
D O I
10.2147/JHC.S412933
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Using a combination model of preoperative imaging and clinical factors to predict non-transplantable recurrence (NTR) after liver resection and assist solitary hepatocellular carcinoma (HCC) patients in the selection of early treatment options. Patients and Methods: A retrospective analysis was conducted on 253 solitary HCC patients who underwent radical resection and had preoperative MRI. NTR patients were defined as those exceeding the University of California, San Francisco (UCSF) criteria at the time of recurrence. Cox regression analysis was employed to identify preoperative factors associated with NTR based on clinical and tumor imaging characteristics. A risk scoring model (NTRScore) was developed and validated. Results: Among the 253 patients, 86 (33.9%) experienced recurrence, and among those with recurrence, 34 patients (39.5%) developed NTR. In multivariate analysis, factors associated with NTR included alpha-fetoprotein (AFP) [>10 ng/mL] [HR: 3.42, 95% confidence interval (CI): 1.54-7.63, P: 0.003], arterial phase hyperenhancement (APHE) [HR: 2.23, 95% CI: 1.03-4.81, P: 0.041], washout[HR: 0.35, 95% CI: 0.15-0.84, P: 0.019], and capsule [HR: 0.44, 95% CI: 0.22-0.88, P: 0.021]. The beta-coefficients of these variables were utilized to develop the weighted NTRScore(c-index 0.72, 95% CI: 0.65-0.79). The NTR occurrence increased across the three categories (low: 5.6%, medium: 13.6%, high: 35.1%, p < 0.001), and the Kaplan-Meier curves of recurrence-free survival(RFS) and overall survival(OS) show significant differences (p = 0.004 and p<0.001). Furthermore, the higher NTR categories may be associated with an increased risk of extrahepatic recurrence. Conclusion: The NTRScore demonstrated strong discriminatory ability and may serve as a clinically useful tool to assist in risk stratification and potential to guide treatment and optimal surveillance for patients of solitary hepatocellular carcinoma within UCSF criteria.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 35 条
[1]  
American College of Radiology, Liver Imaging Reporting and Data System
[2]   Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection [J].
An, Chansik ;
Kim, Dong Wook ;
Park, Young-Nyun ;
Chung, Yong Eun ;
Rhee, Hyungjin ;
Kim, Myeong-Jin .
RADIOLOGY, 2015, 276 (02) :433-443
[3]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[4]   Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients [J].
Chernyak, Victoria ;
Fowler, Kathryn J. ;
Kamaya, Aya ;
Kielar, Ania Z. ;
Elsayes, Khaled M. ;
Bashir, Mustafa R. ;
Kono, Yuko ;
Do, Richard K. ;
Mitchell, Donald G. ;
Singal, Amit G. ;
Tang, An ;
Sirlin, Claude B. .
RADIOLOGY, 2018, 289 (03) :816-830
[5]  
Chow P., 2023, CANCER RES, V83, pCT003, DOI [10.1158/1538-7445.AM2023-CT003, DOI 10.1158/1538-7445.AM2023-CT003]
[6]   Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria [J].
Duvoux, Christophe ;
Roudot-Thoraval, Francoise ;
Decaens, Thomas ;
Pessione, Fabienne ;
Badran, Hanaa ;
Piardi, Tullio ;
Francoz, Claire ;
Compagnon, Philippe ;
Vanlemmens, Claire ;
Dumortier, Jerome ;
Dharancy, Sebastien ;
Gugenheim, Jean ;
Bernard, Pierre-Henri ;
Adam, Rene ;
Radenne, Sylvie ;
Muscari, Fabrice ;
Conti, Filomena ;
Hardwigsen, Jean ;
Pageaux, Georges-Philippe ;
Chazouilleres, Olivier ;
Salame, Ephrem ;
Hilleret, Marie-Noelle ;
Lebray, Pascal ;
Abergel, Armand ;
Debette-Gratien, Marilyne ;
Kluger, Michael D. ;
Mallat, Ariane ;
Azoulay, Daniel ;
Cherqui, Daniel .
GASTROENTEROLOGY, 2012, 143 (04) :986-+
[7]   Liver resection for hepatocellular carcinoma on cirrhosis - Univariate and multivariate analysis of risk factors for intrahepatic recurrence [J].
Ercolani, G ;
Grazi, GL ;
Ravaioli, M ;
Del Gaudio, M ;
Gardini, A ;
Cescon, M ;
Varotti, G ;
Cetta, F ;
Cavallari, A .
ANNALS OF SURGERY, 2003, 237 (04) :536-543
[8]   Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection? [J].
Fernandez-Sevilla, Elena ;
Allard, Marc-Antoine ;
Selten, Jasmijn ;
Golse, Nicolas ;
Vibert, Eric ;
Cunha, Antonio Sa ;
Cherqui, Daniel ;
Castaing, Denis ;
Adam, Rene .
LIVER TRANSPLANTATION, 2017, 23 (04) :440-447
[9]   Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis [J].
Fuks, David ;
Dokmak, Safi ;
Paradis, Valerie ;
Diouf, Momar ;
Durand, Francois ;
Belghiti, Jacques .
HEPATOLOGY, 2012, 55 (01) :132-140
[10]   The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We? [J].
Hu, Xin ;
Chen, Ronggao ;
Wei, Qiang ;
Xu, Xiao .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02) :536-551